Mayra Serrano

  • Citations Per Year
Learn More
BACKGROUND Treatment summary and survivorship care plan studies are at the forefront of research priorities with precedence for ethnic minority inclusion. This preliminary study joined the advocacy, scientific, and medical communities to inform the development and evaluation of the Treatment Summary and Survivorship Care Plan (TSSCP-S) template targeted for(More)
71 Background: This randomized control study was designed to evaluate the impact of trial participation on access to survivorship care planning (SCP) and adherence to surveillance recommendations among AABCS. METHODS AABCS were recruited from the State Cancer Registry and support groups. This trial consisted of 1:1 randomization into two conditions: 1)(More)
INTRODUCTION Therapeutic management of inborn errors of metabolism (IEMs) is complicated. The drugs involved are classified as orphan, and their supply depends on whether they are orphan medicines, investigational drugs, or need to be prepared as a compounded formula. MATERIALS AND METHODS We analyzed emergency criteria, availability, and permanent(More)
M. Luna Serrano , R. Caballero Hernández , L. M. González Rivas , A. García Molina, A. García Rudolph, C. Cáceres, R. Sánchez Carrión, T. Roig Rovira, J.M. Tormos Muñoz, E.J. Gómez Aguilera 2 Bioengineering and Telemedicine Centre, ETSI Telecomunicación, Universidad Politécnica de Madrid, Av. Complutense 30, 28040, Madrid, Spain. 2 Biomedical Research(More)
Latinas compose almost 10% of the U.S. population and suffer the highest incidence of and one of the highest mortality rates from cervical cancer. Human papillomavirus (HPV) vaccination can prevent most HPV infections that cause more than 90% of cervical cancer. Unfortunately, limited knowledge and low rates of HPV vaccination persist among Latinas. The(More)
146 Background: African and Latina-American breast cancers patients (BCA) experience the greatest morbidity and mortality, suggesting a critical need for improved surveillance and quality care. The Institute of Medicine (IOM) and the Commission on Cancer (CoC) recommend that survivors receive personalized Treatment Summaries and Survivorship Care Plans(More)
  • 1